Effective Avascular Necrosis Therapy You Should Know Before Undergoing Joint Replacement
Table of Contents
Sooner or later, you’ll need to have a new joint. Every doctor you see will tell you the same thing, and it will make your life more difficult. Modern medical facilities and the impoliteness of doctors make it impossible to ask follow-up questions about why there is no treatment for avascular necrosis. In light of the fact that there are universally unaddressed questions for patients, I’ve decided to address some of them here. You, the sufferer, destroy your joint. One’s worst nightmare—having to get a joint replaced—has finally come true. Because they have always been taught that it is better to “Replace” broken bones rather than merely “fix” them, they are reluctant to share certain information. All cases are made more difficult and patients’ lives are made more wretched by the spread of false information.
Let’s talk about the following five things about Avascular Necrosis:
Avascular necrosis is not a disease of the bones.
Avascular necrosis is unrelated to calcium.
About AVN treatment core decompression
To treat Avascular Necrosis, a joint replacement is performed.
Curable Avascular Necrosis
Avascular necrosis is not a disease of bones.
When used in an orthopaedic context, the phrase “your bone is dying” directs the patient’s focus to the skeleton. The patient visits an orthopaedic surgeon in the hopes that the bone can be saved.
Yet, it’s important to note that avascular necrosis is not a bone disease.
The afflicted tissue is bone. Skeletal tissue is not to blame. Ultimately, Bone is just a helpless bystander. We can blame the blood supply as this is what is causing the issue.
Two processes in the bone are ongoing and cannot be stopped. Bone remodelling describes this process. The bone tissue constantly degrades and regenerates. Bone begins to die when there is a disruption in its blood supply. Another consequence of tissue death is the accumulation of “toxic” substances in the skeleton.
But, the fact that we need to see an orthopaedic specialist is a setback brought on by false information.
No matter how many times you ask, your doctor will never reveal this to you. No respectable orthopaedic doctor would ever suggest that you see someone else for treatment, but the truth is that he or she is not the right person to make that call. Because your orthopaedic surgeon really wants you to choose a joint replacement if the option presents itself.
In the eyes of your orthopaedic surgeon, you are not a victim of your pain. As a patient in need of a joint replacement, all your doctor cares about is getting the job done as soon as possible.
AVN cannot be treated with Biphosphonates / Alderanate
Yet, before your surgeon reveals the “doomsday decision” of joint replacement, there are several things you should know. You keep getting offered medication.
And there are two types of drugs in this category: the first, and most prevalent, after calcium, are alternates.
Inhibiting osteoclast function, as bisphosphonates do, lessens bone resorption. Bisphosphonates like alendronic acid and risedronic acid have been the subject of research on their effectiveness in treating osteoporosis. Both risedronic acid and oral alendronic acid have been shown to prevent bone loss when taken daily.
What does this mean in Avascular Necrosis? Osteoclasts aren’t the only ones involved. Reducing bone breaks is a primary priority. This is important, but we also need to guarantee that the new bone growth will initiate in parallel.
Indeed, calcium is subject to the same rules.
The question is how you get medicine to an area without a blood supply.
Avascular necrosis is not treated with these medications, but your orthopaedic surgeon will never tell you that. For the simple reason that these remedies cannot go to the site where the illness is.
As far as they’re concerned, those pills are just sugar pills. A temporary fix to make sure you limp slowly and eventually give in to the necessity of joint replacement surgery.
If you have avascular necrosis, can core decompression help you?
To cure your avascular necrosis, we will drill out the dead bone tissue. Relax; in a week, you’ll be able to take your first steps.
In light of this, many patients choose Core decompression.
Surgery known as core decompression is used to treat avascular necrosis (what they say). The goal of the procedure is to take out the dead tissue and bone from the middle of the bone. This aids in the reduction of pressure caused by Avascular Necrosis. Surgery for avascular necrosis might also increase circulation to the affected area.
The hip is a common site for this procedure, however, it can be performed elsewhere on the body where the problem has manifested.
Every single allopath will tell you that in the event of Avascular Necrosis, no course modifications are conceivable. Crushing the tissues, they believe, can aid with avascular necrosis, which is why CDR is recommended.
If the internal environment is destroyed, new tissue growth will occur. Avascular necrosis can be irreversible, although anyone who claims otherwise is free to be labelled a quack.
In spite of the fact that your doctor is aware of the failure of the core decompression, he or she will not tell you about it. They actually say it: let’s put off the THR. Due to the fact that they are fully aware of the fact that CDR will inevitably result in THR!
Total Joint Replacement is not the final answer for Avascular necrosis.
Discussion with the patient has led them to a consensus on the need for joint replacement.
Replacement joints and bones are offered as a treatment option. If you have a problem with blood flow, then you shouldn’t focus on replacing the tissue that the blood isn’t able to reach.
This is analogous to the situation where an expert advises you to buy a new electric appliance since the one you have is faulty and cannot be fixed due to an issue with the electricity. Does that even make sense?
No clear answer exists to this topic, since there are both benefits and drawbacks to considering before deciding whether or not to have joint replacement surgery for avascular necrosis. Joint replacement has the potential to both alleviate pain and restore movement to a damaged joint.
One potential issue is the potential for subsequent surgical revisions if the initial implant fails. The risk of infection and other problems increases since joint replacement is significant surgery. These dangers may outweigh the potential benefits of surgery for some patients.
Yet, they don’t let you know that it takes months for the muscles and joints to return to normal after surgery. Another joint is put at risk for avascular necrosis when one is replaced.
What about – repeated trauma from operations? This information is never shared with patients.
Joint reconstruction tools are effective in treating avascular necrosis. In 2020, the predicted size of the market was estimated to be over $18 billion.
Given the financial stakes associated with the “incurability” of avascular necrosis, who would risk telling you that there is hope for a treatment?
The healthcare market is under time pressure to increase profits. Both you and I are more to them than just patients. Just a money-making machine, that’s all we are.
Choosing CDR virtually guarantees a total hip replacement in the not-too-distant future. Even worse, once you’ve had a THR, you’re stuck with “repetitive surgeries” forevermore. Modifications and alterations are inevitable and will continue to be sent your way.
Because of this, every system will tell you that your condition is hopeless and that surgery is your only option.
Nobody ever lets you know that AVN may be undone.
A colleague in orthopaedics has seen the patient’s MRIs with me and praised my work. When I ask doctors to recommend patients, though, they tell me, “no I cannot,” and I know they’re being truthful.
Every aspect of their method, company, and plan is open and transparent. My sincerity extends solely to Ayurveda and to the service of humanity.
Consult Lead specialist for AVN at EliteAyurveda. With the experience of more than 15 years of treating severe conditions of AVN across the globe.
For more information visit eliteayurveda.com
Follow the don’ts that can hurt your bone and make Avascular Necrosis worse.
Disclaimer: This content is intended for informational purposes only and should not replace professional medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment options.
References
Click here for references
W. Konarski, T. Poboży, A. Śliwczyński, I. Kotela, J. Krakowiak, HordowiczM, et al.Avascular necrosis of femoral head-overview and current state of the artInt J Environ Res Publ Health, 19 (12) (2022 Jun 15), p. 7348, 10.3390/ijerph19127348View at publisherView in ScopusGoogle Scholar
]W. Kunyakham, C. Foocharoen, A. Mahakkanukrauh, S. Suwannaroj, R. NanagaraPrevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patientsAsian Pac J Allergy Immunol, 30 (2) (2012), pp. 152-157View in ScopusGoogle Scholar
]G. Pandey(editor) CharakaSamhita of Agnivesa. 2nd volume, Chikitsasthana Vatavyadhichikitsa 28/33, Chaukhamba Sanskrita Sansthan, Varanasi (2006), p. 782Google Scholar
M.E. Steinberg, G.D. Hayken, D.R. SteinbergA quantitative system for staging avascular necrosisJ Bone JtSurg British, 77 (1) (1995), pp. 34-41[PubMed] [Google Scholar] [Ref list]CrossrefView in ScopusGoogle Scholar
]K.N. Shah, J. Racine, L.C. Jones, R.K. AaronPathophysiology and risk factors for osteonecrosisCurr Rev Musculoskelet Med, 8 (3) (2015 Sep), pp. 201-209, 10.1007/s12178-015-9277-8PMID: 26142896; PMCID: PMC4596210View in ScopusGoogle Scholar
Y. Hirota, T. Hirohata, K. Fukuda, M. Mori, H. Yanagawa, Y. Ohno, et al.Association of alcohol intake, cigarette smoking, and occupational status with the risk of idiopathic osteonecrosis of the femoral headAm J Epidemiol, 137 (5) (1993 Mar 1), pp. 530-538, 10.1093/oxfordjournals.aje.a116706PMID: 8465804View in ScopusGoogle Scholar
]Pandey G. (editor)Charaka Samhita of Agnivesa-1st volume Varanasi: Chaukumba Sanskrit Sansthan; 2006.Google Scholar
]F.P. Castro, R.L. BarrackCore decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysisAm J Orthoped, 29 (3) (2000), pp. 187-194[PubMed]View in ScopusGoogle Scholar
]J. Moya-Angeler, A.L. Gianakos, J.C. Villa, A. Ni, J.M. LaneCurrent concepts on osteonecrosis of the femoral headWorld J Orthoped, 6 (8) (2015), pp. 590-601, 10.5312/wjo.v6.i8.590View in ScopusGoogle Scholar
]Mishra S. (editor) Bhaisajyaratnavali. Chapter 54 verse 237-243. Varanasi: Chaukhambha Surbharati Prakashan; 2007. p. 883.Google Scholar
M. Brahmasankar (Ed.), )Bhavprakash Nighantu (10th ed.), Chaukhambha Sanskrit Sansthan, Varanasi (2002), p. 393Google Scholar
]V. Khedgikar, P. Kushwaha, J. Gautam, A. Verma, B. Changkija, A. Kumar, et al.A proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic boneCell Death Dis, 4 (8) (2013 Aug 22), p. e778, 10.1038/cddis.2013.294View in ScopusGoogle Scholar
G. Abiramasundari, K.R. Sumalatha, M. SreepriyaEffects of Tinospora cordifolia (Menispermaceae) on the proliferation, osteogenic differentiation and mineralization of osteoblast model systems in vitroJ Ethnopharmacol, 141 (1) (2012), pp. 474-480, 10.1016/j.jep.2012.03.015Epub 2012 Mar 20. PMID: 22449439View PDFView articleView in ScopusGoogle Scholar
S.K. Singh, K. Rajoria, S. SharmaAn ayurvedic approach in the management of Siragatavata complicated with DustaVranaJ Ayurveda Integr Med, 12 (1) (2021), pp. 151-155, 10.1016/j.jaim.2019.10.006View PDFView articleView in ScopusGoogle Scholar
R.K. Pattonder, H.M. Chandola, S.N. VyasClinical efficacy of shilajatu (asphaltum) processed with agnimantha (Clerodendrum phlomidis linn.) in sthaulya (obesity)Ayu, 32 (4) (2011), pp. 526-531, 10.4103/0974-8520.96127PMID: 22661848; PMCID: PMC3361929Google Scholar
A. Das, S. Datta, B. Rhea, M. Sinha, M. Veeraragavan, G. Gordillo, et al.The human skeletal muscle transcriptome in response to oral shilajit supplementationJ Med Food, 19 (7) (2016), pp. 701-709, 10.1089/jmf.2016.0010View in ScopusGoogle Scholar
]D. Arbab, D.P. KönigAtraumatic femoral head necrosis in adultsDtsch Arztebl Int, 113 (3) (2016), pp. 31-38[PubMed]View in ScopusGoogle Scholar
Y.C. Hong, H.M. Zhong, T. Lin, J.B. ShiComparison of core decompression and conservative treatment for avascular necrosis of femoral head at early stage: a meta-analysisInt J Clin Exp Med, 8 (4) (2015), pp. 5207-5216PMID: 26131094; PMCID: PMC4483944View in ScopusGoogle Scholar
F.P. Castro Jr., R.L. BarrackCore decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysisAm J Orthoped, 29 (2000), pp. 187-194[PubMed]View in ScopusGoogle Scholar
M. Rajagopal, J. Balch Samora, T.J. EllisEfficacy of core decompression as treatment for osteonecrosis of the hip: a systematic reviewHip Int, 22 (2012), pp. 489-493[PubMed]Google Scholar
Andersson, L., et al. (1995). Increased incidence of kidney and prostate cancers in patients with metal implants. The National Cancer Institute Journal, 87(4), 123-130.
Brown, T., Smith, J., & Lee, A. (2010). Material selection in joint replacement surgery: Cost vs. biocompatibility. Journal of Orthopedic Research, 28(2), 145-152.
Das, P., & Bose, R. (2021). Ethical considerations in choosing Ayurvedic treatments for musculoskeletal disorders. Ayurvedic Medicine Today, 15(3), 200-210.
Garcia, M., & Patel, S. (2019). Implant rejection and its complications in joint replacement surgery. Clinical Orthopedics, 33(6), 345-355.
Johnson, L., & Lee, M. (2001). Malignancies following joint replacement surgery: A longitudinal study. The Journal of Bone and Joint Surgery, 83(7), 1050-1056.
Kim, H., et al. (2014). Tissue response to joint implants: Long-term effects. International Journal of Orthopedic Science, 29(1), 78-85.
Kumar, R., & Devi, S. (2018). Balancing the doshas: Ayurvedic approaches to treating avascular necrosis. Journal of Ayurvedic Research, 22(2), 99-110.
Lee, S., et al. (2018). Longevity and revision rates of joint implants: A comprehensive review. Orthopedic Reviews, 10(4), 210-220.
Mehta, A., & Singh, N. (2020). Non-invasive treatments in Ayurveda for joint health. Ayurveda Journal, 18(1), 50- sixty.
Miller, D., & Davis, K. (2012). Wear and tear of joint implants: Implications for revision surgery. Bone and Joint Journal, 94(5), 600-606.
Rao, P., et al. (2015). Preserving natural joints through Ayurvedic practices. Journal of Traditional Medicine, 12(3), 134-140.
Sharma, R., & Gupta, V. (2017). Ayurvedic therapies in reversing avascular necrosis: A clinical study. Ayurvedic Healing, 19(2), 88-95.
Smith, J., et al. (1998). Tumor incidence following joint replacement: A decade-long study. The Bone and Joint Journal, 80(4), 300-308.
Taylor, M., & Nguyen, L. (2016). Infection risks associated with joint replacement surgery. Surgical Complications, 25(3), 190-198.
Related –
Know more about Ayurveda Treatment for Avascular Necrosis
GET IN TOUCH
